- Drugs
- Monday, 04 May 2020
Pharmaceutics International Selected as A Winner of Two GH&P Awards
Pharmaceutics International, Inc. (Pii), a US-based Contract Development and Manufacturing Organization (CDMO) today announced it has won the 2020 CDMO Leadership Award and was named the Most Innovative Company in Dosage Solutions by Global Health & Pharma Magazine.
"We are honored to be recognized in these two categories. Pii has an extensive range of technologies, skilled personnel and Pharmaceutics Know-How™, to enable the rapid development and reliable production of high-quality sterile and oral dosage forms. It is extremely gratifying to have our innovation, accomplishments and commitment to partners and patients acknowledged," said Dr. Kurt R. Nielsen, Pii's President and CEO.
According to GH&P, "Biotechnology is a huge, varied and ever-growing industry. Operating and succeeding in such an environment which, in many ways, demands excellence at every turn is - it goes without saying - incredibly difficult, yet there are businesses that have learned to thrive under such conditions. To harness innovation and deliver results, driving the greater industry onwards." Jazmin Collins, GH&P Awards Coordinator, commented "Regardless of their size or location, we honor companies from across this vibrant and talented sector."
Related Industry Updates
Idiopathic Pulmonary Fibrosis Treatment Market is expected to reach US$ 10,784.07 million by 2030
Dec 12, 2023
African Americans Struggle to Join Legal Marijuana Industry
Feb 12, 2020
Drug Discovery Services Market is expected to reach US$ 56,783.29 million by 2030
Nov 17, 2023
OTC Drug and Dietary Supplement Market In-depth Research Analysis By The Insight Partners
Jan 05, 2021
Clinic Casting and Splinting Products Market is expected to reach US$ 2,085.57 million by 2030
Aug 02, 2023
Hikma launches Dicyclomine Hydrochloride Oral Solution
May 28, 2020
North America Drug Modelling Software Market Emerging Trends and Prospects 2027 With Leading Players are Chemical Computing Group ULC, Nimbus Therapeutics, Schrödinger, Inc
Dec 30, 2020